Gilead
Gilead pays $45 million to settle kickback case filed by Texas AG
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter. Gilead Sciences agreed to pay $45 million to settle allegations of paying kickbacks that improperly influenced prescriptions paid for by the Texas Medicaid […]
Gilead should provide drug prevention medication in low -income countries
After months of anticipation, Gilead offered an agreement to provide its revolutionary drug on HIV prevention to up to 2 million people in low and intermediate income countries. As part of the New Deal, the Global Fund to combat AIDS, tuberculosis and malaria will be responsible for the purchase and provision of drug doses, known […]
A tragic paradox, Gilead updates and a lot of new pfizer
Adam Feuerstein / Stat Matthew Herper covers medical innovation – both his promise and his perils. Adam Feuerstein is a main writer and biotechnology columnist, reporting on the crossroads of drug development, business, Wall Street and biotechnology. He is also co-host of the weekly biotech podcast The Readout Loud and author of the Biotech dashboard […]